Drugs / G-CSF
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00795613 Background | Jun 2008 → Nov 2014 | Hodgkins lymphoma | Ospedale Santa Croce-Carle Cuneo | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | G-CSF | “G-CSF300mcg/die s/c from day 8 until PMN\>1000/ul” NCT00795613 ↗ |
| Route | Subcutaneous | “G-CSF300mcg/die s/c from day 8 until PMN\>1000/ul” NCT00795613 ↗ |